Skip to content
  • About us
  • Our approach
  • About diabetes
  • News
  • Contact
  • About us
  • Our approach
  • About diabetes
  • News
  • Contact

News

News

DiogenX appoints Dr. Klara Owen as Chief Medical Officer

November 12, 2024

DiogenX welcomes Eleanor L. Ramos as independent member of its Board of Directors

September 9, 2024

DiogenX strengthens Executive Committee with Hélène Sicard joining as Chief Development Officer

July 25, 2024

Sunstone Life Science Ventures Fund IV invests in DiogenX, a biotech company developinga first-in-class regenerative treatment for type 1 diabetes

October 31, 2023

DiogenX raises €27.5M Series A financing to advance its first-in-class regenerative treatment for type 1 diabetes into clinical trial

May 10, 2023

DiogenX Raises €4.5M in Seed Financing from Advent France Biotechnology, Boehringer Ingelheim Venture Fund and JDRF T1D Fund

June 16, 2020

Events

  • 12/11/2024

DiogenX appoints Dr. Klara Owen as Chief Medical Officer

  • 09/09/2024

DiogenX welcomes Eleanor L. Ramos as independent member of its Board of Directors

  • 25/07/2024

DiogenX strengthens Executive Committee with Hélène Sicard joining as Chief Development Officer

  • 31/10/2023

Sunstone Life Science Ventures Fund IV invests in DiogenX, a biotech company developinga first-in-class regenerative treatment for type 1 diabetes

DIOGENX

DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world.

Linkedin

Head office

180 avenue du Prado

13008 Marseille

 

Institut de biologie Valrose

Parc Valrose – Centre de Biochimie

06108 Nice cedex 2 France

 

Privacy Policy

Manage Consent

We use cookies to improve your experience. You can accept or decline their use. Your choice may affect certain features of the site.

Functional Always active
Access or technical storage is strictly necessary for the legitimate interest of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of transmitting a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
Storage or technical access used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}